Lewis, Joshua P <br/><br/>
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients.  [electronic resource] 

 -  European heart journal. Cardiovascular pharmacotherapy  07 2020 
 - 203-210 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2055-6845 
<br/><br/><label>Standard No.: </label>10.1093/ehjcvp/pvz045  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Brain Ischemia--mortality<br/>Clopidogrel--adverse effects<br/>Coronary Artery Disease--blood<br/>Coronary Thrombosis--mortality<br/>Decision Support Techniques<br/>Europe<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--mortality<br/>Percutaneous Coronary Intervention--adverse effects<br/>Pharmacogenomic Variants<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Polymorphism, Single Nucleotide<br/>Predictive Value of Tests<br/>Risk Assessment<br/>Risk Factors<br/>Stents<br/>Stroke--mortality<br/>Treatment Outcome